| Discovery and resupply of pharmacologically active plant-derived natural products: A review AG Atanasov, B Waltenberger, EM Pferschy-Wenzig, T Linder, ... Biotechnology advances 33 (8), 1582-1614, 2015 | 1399 | 2015 |
| Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review L Wang, B Waltenberger, EM Pferschy-Wenzig, M Blunder, X Liu, ... Biochemical pharmacology 92 (1), 73-89, 2014 | 483 | 2014 |
| Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase AG Atanasov, LG Nashev, RAS Schweizer, C Frick, A Odermatt FEBS letters 571 (1-3), 129-133, 2004 | 240 | 2004 |
| Ethnopharmacological in vitro studies on Austria's folk medicine—An unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs S Vogl, P Picker, J Mihaly-Bison, N Fakhrudin, AG Atanasov, EH Heiss, ... Journal of Ethnopharmacology 149 (3), 750-771, 2013 | 238 | 2013 |
| Inflammatory markers for arterial stiffness in cardiovascular diseases I Mozos, C Malainer, J Horbańczuk, C Gug, D Stoian, CT Luca, ... Frontiers in immunology 8, 1058, 2017 | 164 | 2017 |
| Autophagy and Alzheimer’s disease: from molecular mechanisms to therapeutic implications M Uddin, A Stachowiak, AA Mamun, NT Tzvetkov, S Takeda, AG Atanasov, ... Frontiers in Aging Neuroscience 10, 4, 2018 | 162 | 2018 |
| A critical analysis of extraction techniques used for botanicals: Trends, priorities, industrial uses and optimization strategies T Belwal, SM Ezzat, L Rastrelli, ID Bhatt, M Daglia, A Baldi, HP Devkota, ... TrAC Trends in Analytical Chemistry 100, 82-102, 2018 | 146 | 2018 |
| Activated AMPK boosts the Nrf2/HO-1 signaling axis—a role for the unfolded protein response K Zimmermann, J Baldinger, B Mayerhofer, AG Atanasov, VM Dirsch, ... Free Radical Biology and Medicine 88, 417-426, 2015 | 144 | 2015 |
| The role of nutraceuticals in statin intolerant patients M Banach, AM Patti, RV Giglio, AFG Cicero, AG Atanasov, G Bajraktari, ... Journal of the American College of Cardiology 72 (1), 96-118, 2018 | 129 | 2018 |
| A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanone selectively inhibits 11β-HSD1 reductase activity RAS Schweizer, AG Atanasov, BM Frey, A Odermatt Molecular and cellular endocrinology 212 (1-2), 41-49, 2003 | 128 | 2003 |
| Honokiol: a non-adipogenic PPARγ agonist from nature AG Atanasov, JN Wang, SP Gu, J Bu, MP Kramer, L Baumgartner, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (10), 4813-4819, 2013 | 122 | 2013 |
| A comprehensive review on MAPK: a promising therapeutic target in cancer C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ... Cancers 11 (10), 1618, 2019 | 111 | 2019 |
| Natural products to counteract the epidemic of cardiovascular and metabolic disorders B Waltenberger, A Mocan, K Šmejkal, EH Heiss, AG Atanasov Molecules 21 (6), 807, 2016 | 93 | 2016 |
| Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates AG Atanasov, S Tam, JM Röcken, ME Baker, A Odermatt Biochemical and biophysical research communications 308 (2), 257-262, 2003 | 89 | 2003 |
| Why is 11β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen?: Physiological relevance of the membrane topology of 11β-HSD1 A Odermatt, AG Atanasov, Z Balazs, RAS Schweizer, LG Nashev, ... Molecular and cellular endocrinology 248 (1-2), 15-23, 2006 | 88 | 2006 |
| Antioxidants: scientific literature landscape analysis AWK Yeung, NT Tzvetkov, OS El-Tawil, SG Bungǎu, MM Abdel-Daim, ... Oxidative medicine and cellular longevity 2019, 2019 | 87 | 2019 |
| Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance A Odermatt, C Gumy, AG Atanasov, AA Dzyakanchuk The Journal of steroid biochemistry and molecular biology 102 (1-5), 222-231, 2006 | 81 | 2006 |
| Organotins disrupt the 11β-hydroxysteroid dehydrogenase type 2–dependent local inactivation of glucocorticoids AG Atanasov, LG Nashev, S Tam, ME Baker, A Odermatt Environmental health perspectives 113 (11), 1600-1606, 2005 | 81 | 2005 |
| Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention D Tewari, SF Nabavi, SM Nabavi, A Sureda, AA Farooqi, AG Atanasov, ... Pharmacological Research 128, 366-375, 2018 | 78 | 2018 |
| Direct protein–protein interaction of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen AG Atanasov, LG Nashev, L Gelman, B Legeza, R Sack, R Portmann, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1783 (8), 1536-1543, 2008 | 77 | 2008 |
Judith RollingerUniversity of ViennaVerified email at univie.ac.at
